In December 2019, 3M Company, Inc. agreed to sell its pharmaceutical delivery business to Altaris Capital Partners, LLC.
As part of the deal, Altaris Capital Partners, LLC would invest US$ 650 million in 3M Company.
The agreement will aid in the growth of the medication delivery business and the manufacturing of pharmaceutical items using cutting-edge inhalation, epidermal, microneedle, and classic drug delivery technologies.
The Effects of the COVID-19 Pandemic
The COVID-19 epidemic has had an impact on markets around the world, and it is expected to hamper raw material supply for the production of microneedle flu vaccines.
Furthermore, the COVID-19 pandemic has impacted the global Microneedle Flu Vaccine Market in three ways:
directly affecting production and demand; causing distribution networks to be disrupted
Read More @ https://cmiinfopiece.blogspot.com/2021/11/microneedle-flu-vaccine-market-by.html
